Hold Rating Given for Zanzalintinib Based on STELLAR-001 Trial Outcomes
Stifel Nicolaus analyst Stephen Willey has maintained their neutral stance on EXEL stock, giving a Hold rating today.Invest with Confidence: ...
Analysts Conflicted on These Healthcare Names: Atricure (ATRC) and Hims & Hers Health (HIMS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report) and Hims ...
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...
Xponential Fitness, Inc. (NYSE:XPOF) Given Consensus Recommendation of “Moderate Buy” by Analysts
Xponential Fitness, Inc. (NYSE:XPOF – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten ...
Hut 8 Corp. (NASDAQ:HUT) Receives Average Recommendation of “Buy” from Analysts
Shares of Hut 8 Corp. (NASDAQ:HUT – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages ...
Stifel maintains Buy on Evolus, price target steady at $25
Stifel analysts maintained a Buy rating on Evolus (NASDAQ:EOLS) with a steady price target of $25.00. The firm's positive ...
Stifel cuts Fastenal price target to $82, maintains Hold
The upward movement in Fastenal (NASDAQ:FAST)'s stock was also attributed to stronger than expected December housing starts ...
manilatimes10h
Transaction in Own Shares
Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 243,801,985 ordinary shares in issue. Therefore the total voting rig ...